1) 🇩🇪 There's more info about the trial on Aripiprazole (Abilify) that will take place in the Charité.
It will enrol 138 PAIS patients using a crossover design so everyone will be on 1 mg of Abilify for a period of 8 weeks. Primary outcome is the Chalder Fatigue Scale.
